LifeStance selling stockholders price 35 million-share secondary offering at $8.15/share

LifeStance Health

LifeStance Health

LFST

0.00
  • LifeStance Health priced secondary underwritten public offering of 35,000,000 common shares at USD 8.15 per share.
  • Selling stockholders will receive all proceeds; LifeStance is not selling shares in offering.
  • Company agreed to purchase 6,000,000 shares from underwriter at same per-share price paid to selling stockholders; repurchase conditioned on offering close.
  • Offering expected to settle and close on or about May 12, 2026; repurchase not a condition to offering.
  • J.P. Morgan acting as underwriter.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeStance Health Group Inc. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.